Canadian researchers to start clinical trials of HIV vaccine

December 21, 2011 at 9:34 am Leave a comment

A team led by Dr. Chil-Yong Kang, a virologist at the University of Western Ontario in London, Ont., will start Phase 1 clinical trials on 40 HIV-positive patients to test the safety of this new vaccine.

“FDA approval for human clinical trials is an extremely significant milestone for our vaccine, which has the potential to save the lives of millions of people around the world by preventing HIV infection,” Kang said in a news release.

Read more: http://www.canada.com/health/Canadian+researchers+start+clinical+trials+vaccine+January/5887090/story.html#ixzz1hB98bVuk

Entry filed under: Biotechnology News. Tags: , , , , , , , , , .

How to ensure significant results from your qPCR studies Canadian biotech set to grow 9.4% year to 2030

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


biorad1

Bio-Rad Canada has sponsored the development of this site to advance the productivity of the Canadian Biotechnology sector and the fine people who work in it across the country.  We invite readers to contribute content: posters, tools, research and presentations, articles white papers, multimedia, music downloads and entertainment, conference announcements, videos. Please contact info@cbt20.ca for more information.

Bookmark and Share

Site developed by What If What Next(TM)

Follow us on Twitter


%d bloggers like this: